Niharika Dixit

So excited to announce, alongside chairs @drannekatz.bsky.social and Dr. Linda Bosserman, we will be offering an interactive workshop on sexuality after cancer, held in conjunction with #massc25
Stay tuned for more details!

31.01.2025 16:34 — 👍 13    🔁 5    💬 1    📌 1

The OncoAlert Video Journal: Cancer Statistics 2025 by Rebecca Siegel Et al.
youtu.be/Gd7o17emuRA

The 2025 American Cancer Society report estimates 2,041,910 new cancer cases and 618,120 deaths in the U.S. While cancer mortality has declined since 1991, racial disparities persist.

31.01.2025 13:32 — 👍 3    🔁 1    💬 0    📌 0

Group medical visits in cancer survivorship care: a scoping review

Group medical visits could be a key component of multidisciplinary care for cancer survivors. We summarize existing data on multidisciplinary group medical visits in cancer survivorship and emphasize the need for further research, including evaluation of ongoing initiatives in this space.

27.12.2024 16:52 — 👍 1    🔁 0    💬 0    📌 0

Grief Makes Us Time Travelers (Gift Article) A neuroscientist studying memory, I used to believe time was linear. Then my mother had a stroke.

As an oncologist, I get constant reminders that holidays are joyful & meaningful milestones, but not every yr & not for everyone. If you are with #grief, I hope this will remind you that you belong to something vast & are not alone.

#MedSky #OncSky #LongCovid

www.nytimes.com/2024/12/20/s...

20.12.2024 17:08 — 👍 95    🔁 29    💬 9    📌 2

Dr. Bianchini describes the 🐘 in the room at #SABCS24.

❓Are PD-L1 and PD1 not created equal in breast?

🔑It is clear, neoadjuvant compared to adj immunotherapy should be given

⚠️ highlights ER low should be included in ICI trials

#SABCS24
@sabcs.bsky.social
@oncoalert.bsky.social

13.12.2024 16:50 — 👍 13    🔁 5    💬 1    📌 0

Perfect home for your supportive and survivorship care research. #MASCC25 #SuppOnc

13.12.2024 17:48 — 👍 3    🔁 0    💬 0    📌 0

Congratulations!! on this much needed work. Consider submitting it at #MASCC25 annual meeting.

11.12.2024 23:21 — 👍 2    🔁 0    💬 0    📌 0

What about delayed immune mediated toxicity?
Jacobs et al:
700 pts all stages; 84% TNBC, 74% Early-stage
Incidence: 61% iTox any time; 34% delayed iTox

8.6% with iTox AFTER TREATMENT
4.7% with iTox 1 year AFTER ICI INITIATION

Should we be checking endocrine labs for years after ICI ?
#SABCS24

11.12.2024 14:17 — 👍 5    🔁 2    💬 0    📌 0

Yay!!

21.11.2024 23:52 — 👍 1    🔁 0    💬 0    📌 0